Site Search

... with the right treatment at the right time through biomarker testing .  The bill would ensure more patients with private insurance will have health insurance coverage for the biomarker testing they need. SB24-124 will affect medical health coverage plans for over one million Coloradans or roughly 33% of those with private health insurance coverage. Unfortunately, the bill does ... improve access to biomarker testing for Medicaid enrollees, which accounts for more than 1.6 Coloradans, according to the Department of Health Care Policy and Financing.  “Biomarker testing can be game changing for many cancer patients,” said R.J. Ours, ACS CAN Colorado government ...

... testing to precisely identify the mutations unique to a patient’s cancer. Biomarker testing has revolutionized the entire approach to oncology care. We have seen tremendous gains in the understanding and adoption of biomarker testing over the last five years. The results from such testing ... At FCS, we are acutely aware of the long-term cost savings associated with biomarker testing that reduces the financial burden on the health care system. The ability to tailor therapies to specific cancer traits may lead to improved clinical outcomes and cost reduction. The goal of a ...

... the last few decades and is increasingly important in the treatment of other conditions, providing access to targeted treatment and tailoring care to a person’s individual disease. When American Cancer Society Cancer Action Network (ACS CAN) volunteer Matt Wilson underwent treatment for ... to prioritize patients and pass the proposal without delay. “For thousands of patients in Delaware, biomarker testing has meant more effective care and better outcomes, offering renewed hope. Yet, too many people still struggle to access this testing due to barriers, including inadequate ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment.  “Furthermore, copay accumulator legislation ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...